EntreWealth’s Bristol-Myers Squibb BMY Stock Holding History

EntreWealth’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$221K	Buy	+3,547	New	+$224K	0.08%	144

Other funds holding BMY

Pzena Investment Management New York $34.1B AUM 26.62% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $57B AUM 43.56% 1-Year Est. Return

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

Fort Washington Investment Advisors Cincinnati, Ohio $19.7B AUM 20.11% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

EntreWealth's BMY Position: Q3 2026 in Review

EntreWealth opened a new position in Bristol-Myers Squibb (BMY) in Q3 2026: 3,547 shares worth $221K. The stake represents 0.08% of the portfolio and ranks #144 among its holdings.

1,093 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

EntreWealth held 3,547 shares of Bristol-Myers Squibb worth $221K as of Q3 2026.
Bristol-Myers Squibb was a new EntreWealth position in Q3 2026.
Bristol-Myers Squibb made up 0.08% of EntreWealth's portfolio in Q3 2026, its #144 holding.
1,093 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on EntreWealth's 13F filing for Q3 2026, filed 14 Oct 2026.